Telehealth Narcolepsy Prescribing: What Psychiatrists Can Do in California

If you’re a psychiatrist or PMHNP considering treating narcolepsy patients via telehealth, you’re probably asking the same questions your colleagues are: Can I legally prescribe stimulants remotely? What are the state-by-state rules? Is this even worth my time?

The short answer: Yes, you can treat narcolepsy via telehealth in most states — but the details matter a lot. Whether you’re an MD with full prescriptive authority or a nurse practitioner navigating state scope-of-practice laws, understanding the regulatory landscape is crucial. Even more important: knowing how to make narcolepsy care work for your practice without drowning in paperwork or compliance headaches.

Let’s cut through the confusion.

Why Narcolepsy Patients Need You (And Why Most Don’t Get Help)

Narcolepsy affects roughly 1 in 2,000 Americans — about 160,000 people living with a condition that causes overwhelming daytime sleepiness, sudden sleep attacks, and sometimes cataplexy (sudden muscle weakness triggered by emotions). Despite being a serious, often disabling disorder, most narcolepsy patients go years before getting diagnosed and many never find consistent, knowledgeable care.

Here’s the problem: narcolepsy sits in a clinical no-man’s-land. It’s technically a neurological sleep disorder, so many psychiatrists think it’s outside their scope. Sleep specialists are few and far between (especially in rural areas), and their wait times can stretch months. Primary care providers often lack the comfort level to prescribe the controlled substances narcolepsy requires — Schedule II stimulants like Adderall or methylphenidate, or the highly regulated sodium oxybate (Xyrem).

That’s where you come in. As a psychiatrist or experienced PMHNP, you already have the clinical skills and DEA authority to manage these medications. You understand controlled substance safety, you’re comfortable with medication titration, and you know how to assess psychiatric comorbidities that often accompany narcolepsy (depression, anxiety, ADHD). Add telehealth to the mix, and you can reach patients who literally cannot find local help.

The business case is straightforward: narcolepsy patients need monthly or quarterly medication management (stimulants require regular monitoring and can’t be prescribed in bulk due to DEA rules). These focused 15-20 minute visits are efficient, billable at standard E/M codes, and create a stable patient panel with predictable revenue. Unlike one-off consultations, narcolepsy care is ongoing — patients stay with providers who ‘get it’ and can reliably prescribe what they need.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Federal Telehealth Rules: The Extended DEA Waiver Through 2025

Let’s start with the big question: Can you prescribe controlled substances for narcolepsy via telehealth without an in-person exam?

As of early 2026, the answer is yes — thanks to ongoing DEA flexibilities extended from the COVID public health emergency.

Normally, the Ryan Haight Act requires an in-person medical evaluation before any provider can prescribe Schedule II-V controlled substances. During the pandemic, the DEA suspended that requirement to enable telehealth access. That waiver has been extended through at least December 31, 2025, meaning you can currently conduct a video evaluation and prescribe Adderall, modafinil, or other narcolepsy medications to a new patient entirely online — no in-person meeting required first.

What this means for you:

• Initial narcolepsy evaluations can happen via secure video
• You can prescribe stimulants (Schedule II) and wakefulness agents (Schedule IV modafinil) after a compliant telehealth visit
• Follow-up medication management is fully remote
• You must still comply with state telehealth laws (some states add restrictions beyond federal rules)

After 2025: The DEA has signaled it will create a permanent telemedicine registration pathway, but details are still pending. Be prepared for potential changes — possibly requiring a ‘special registration’ for telehealth prescribing or mandating an in-person exam within 30 days of initial prescribing. Most advocacy groups (APA, AANP) are pushing for permanent flexibility given the success of telehealth for controlled substances during 2020-2025.

For now, you’re covered. Just ensure you’re documenting thoroughly (the same standard of care as in-person), using audio-video technology (phone-only typically doesn’t meet the standard for controlled substance prescribing), and checking your state’s prescription drug monitoring program (PDMP) before every controlled prescription.

Psychiatrists: Your Full Scope in Narcolepsy Care

If you’re a psychiatrist (MD or DO), you have unrestricted prescriptive authority for narcolepsy medications in every state. Your scope is identical to a neurologist or sleep specialist when it comes to pharmacotherapy — you can prescribe:

• Schedule II stimulants: amphetamine salts (Adderall), methylphenidate (Ritalin, Concerta), dextroamphetamine
• Schedule IV wakefulness agents: modafinil (Provigil), armodafinil (Nuvigil)
• Newer medications: solriamfetol (Sunosi), pitolisant (Wakix) — non-controlled
• Sodium oxybate (Xyrem, Xywav) for narcolepsy with cataplexy — Schedule III, requires REMS enrollment
• Adjunct meds: SSRIs or SNRIs for cataplexy, bedtime sedatives if needed

Telehealth Workflow for Psychiatrists

Here’s what a compliant narcolepsy telehealth practice looks like:

1. Initial evaluation (30-45 min):

• Review sleep study results (PSG/MSLT) or coordinate referral for diagnostic testing
• Take full medical/psychiatric history (screen for comorbid ADHD, depression, anxiety)
• Assess current symptoms: Epworth Sleepiness Scale, frequency of sleep attacks, presence of cataplexy
• Check state PDMP for any controlled substance history
• Discuss treatment options and obtain informed consent for stimulant therapy
• E-prescribe medication (must use DEA-compliant EPCS system)

1. Follow-up visits (15-20 min, typically monthly at first):

• Symptom check: improvement in wakefulness, any breakthrough sleep attacks
• Side effect monitoring: BP, heart rate, appetite, mood changes
• Dose adjustments as needed
• Review PDMP for any concerning patterns
• Refill prescriptions (Schedule II requires new prescription monthly — no refills allowed)

1. Coordination:

• Communicate with sleep specialists if patient needs diagnostic workup
• Interface with primary care for general medical issues (hypertension, etc.)
• Provide documentation for workplace/school accommodations if needed

Billing: Code these as standard E/M visits. Initial evaluation: 99204 or 99205 (45-60 min). Follow-ups: 99213 or 99214 (15-30 min). Most insurers reimburse telehealth at parity with in-person in states with parity laws (CA, NY, IL, TX, FL, PA all have some form of telehealth parity).

State-specific caveats for MDs:

Even though psychiatrists have full authority nationwide, a few states impose telehealth-specific restrictions on controlled substances:

• Florida: Technically prohibits prescribing Schedule II via telehealth unless it’s for a ‘psychiatric disorder’ or other defined exception. Narcolepsy is neurological, not psychiatric — but many Florida psychiatrists work around this by using Schedule IV alternatives (modafinil) for initial management, or ensuring at least one in-person visit. If the patient also has ADHD, you could justify Schedule II under the psychiatric exception.

• Texas: No explicit prohibition on physician telehealth prescribing of controlled substances. You must establish a valid physician-patient relationship via video, but once that’s done, you can manage narcolepsy normally.

• California, New York, Illinois, Pennsylvania: No physician-specific telehealth restrictions on controlled substances. Full practice as long as you follow federal DEA rules.

Bottom line for psychiatrists: Your main limitations are federal DEA requirements and your state’s general telehealth standards — not your medical license scope. You can fully manage narcolepsy remotely.

PMHNPs: Navigating State-by-State Prescribing Authority

This is where it gets complicated. If you’re a Psychiatric-Mental Health Nurse Practitioner, your ability to prescribe narcolepsy medications independently depends entirely on which state you’re licensed in.

Full Practice States (NP Independence After Experience)

California: AB 890 created a pathway to independence. As of 2023, experienced NPs can practice in group settings without individual physician oversight (Category 103 NP). After 3 years and 4,600 hours, you can apply for Category 104 status starting in 2026 — full independent practice with no physician collaboration required. Until then, you need a standardized procedure agreement with a physician that covers Schedule II prescribing (historically required patient-specific protocols for each Schedule II drug). Once you’re a 104 NP, you can independently manage narcolepsy patients and prescribe stimulants just like an MD.

New York: After 3,600 hours of practice (roughly 2 years full-time) under a collaborative agreement, you no longer need any written agreement or physician oversight. A fully independent NY NP can prescribe Schedule II-V controlled substances, including all narcolepsy medications. You must check the I-STOP PDMP before every controlled prescription and use e-prescribing. New NPs (under 3,600 hours) still need a written collaborative agreement that explicitly authorizes controlled substance prescribing.

Illinois: Full Practice Authority available after 4,000 hours of clinical experience under a collaborative agreement + 250 hours of continuing education. Once you have FPA, you can prescribe Schedule II-V independently — with one caveat: Illinois requires FPA NPs to maintain a ‘consultation relationship’ with a physician and document monthly discussions only for Schedule II narcotics (opioids) and requires physician consultation if prescribing benzodiazepines for more than 120 days. Stimulants are not mentioned, so an Illinois FPA-NP can prescribe Adderall or modafinil for narcolepsy without mandated physician involvement. This makes Illinois one of the most NP-friendly states for narcolepsy care.

Restricted Practice States (Physician Supervision Required)

Texas: This is the most restrictive state for NPs treating narcolepsy. Texas requires a Prescriptive Authority Agreement with a supervising physician for all APRN prescribing. More importantly, Texas law prohibits NPs and PAs from prescribing Schedule II controlled substances for outpatients — period. The only exceptions are hospital inpatient care (24+ hour admission) or hospice.

What this means: A Texas PMHNP cannot prescribe Adderall or Ritalin for an outpatient narcolepsy patient. You would need your collaborating physician to write those prescriptions, or you could manage the patient with Schedule III-IV alternatives (modafinil, Xyrem if enrolled in the REMS program). The supervising physician can delegate Schedule III-V prescribing, with a 90-day supply limit and required documentation of physician consultation for refills.

Florida: Requires a collaborative agreement with a supervising physician (PMHNPs are excluded from the state’s autonomous NP pathway). Florida APRNs can prescribe Schedule II, but are limited to a 7-day supply maximum — unless you’re a state-certified ‘psychiatric nurse’ prescribing for a psychiatric disorder. Since narcolepsy is not psychiatric, you’re technically bound by the 7-day limit, which means writing four separate prescriptions per month for a stimulant (cumbersome but legal). Many Florida NPs have their collaborating physician handle ongoing Schedule II scripts to avoid this headache. You can prescribe modafinil (Schedule IV) without the 7-day restriction.

Additionally, Florida’s telehealth law still restricts Schedule II prescribing via telemedicine unless it’s for psychiatric treatment, inpatient care, or hospice. So even with a collaborative agreement, you may need to coordinate at least one in-person visit or use Schedule IV alternatives.

Pennsylvania: Requires a written collaborative agreement with a physician. PA CRNPs can prescribe Schedule II drugs for up to 30 days (notify physician within 24 hours), and Schedule III-IV for up to 90 days. Any longer supply requires physician approval. The collaborative physician doesn’t co-sign every script, but they must be available for consultation and review a portion of charts. This is workable for narcolepsy — monthly follow-ups and 30-day stimulant prescriptions align with best practice anyway — but it’s more restrictive than full independence.

Practical Implications for NPs

If you’re in CA, NY, or IL: Once you meet the experience threshold, you can build a narcolepsy telehealth practice almost identical to a psychiatrist’s. You’ll prescribe independently, manage patients long-term, and bill under your own NPI.

If you’re in TX, FL, or PA: You need a physician collaborator to either write certain prescriptions (TX) or oversee your practice (PA/FL). This doesn’t mean you can’t treat narcolepsy — it just means you need the right team setup. Many telehealth platforms (like Klarity) can facilitate collaborative agreements or pair you with a supervising psychiatrist to ensure compliance.

The key is knowing your state’s rules cold and practicing within your legal scope. Violating scope-of-practice laws or prescribing beyond your authority is a fast track to board complaints and DEA scrutiny.

State-by-State Breakdown: What You Need to Know

Medication Management: What Actually Works in Telehealth

Narcolepsy medication management via telehealth isn’t experimental — it’s been proven effective during 2020-2025 when thousands of patients shifted to remote care. Here’s what the workflow looks like in practice:

First-Line Medications

Modafinil/Armodafinil (Schedule IV): Often the starting point. Fewer abuse concerns than amphetamines, easier prior authorizations, and effective for many patients. Can be prescribed in all states via telehealth without major restrictions. Typical dose: 100-400 mg daily.

Amphetamine Stimulants (Schedule II): Adderall, Dexedrine — more potent, often needed when modafinil doesn’t provide enough wakefulness. Higher doses than ADHD (sometimes 60+ mg/day split into 2-3 doses). Requires monthly prescriptions, PDMP checks, and careful monitoring for cardiac side effects and tolerance.

Methylphenidate (Schedule II): Ritalin, Concerta — alternative to amphetamines, some patients respond better. Same DEA restrictions as above.

Newer Agents: Solriamfetol (Sunosi) and pitolisant (Wakix) — non-controlled, effective, but expensive and often require prior auth. Good options for patients with substance use concerns or in states with tighter controlled substance restrictions.

Sodium Oxybate (Schedule III): Xyrem/Xywav — highly effective for narcolepsy with cataplexy, but requires REMS enrollment (prescriber certification + central pharmacy dispensing). Only prescribed by providers comfortable with the program’s requirements.

Monitoring and Safety

Monthly visits during titration are standard. Once stable, many patients can be seen quarterly. Each visit should include:

• Symptom assessment: Sleep attacks, Epworth score, functional impact
• Side effects: Blood pressure (ask patient to use home cuff), heart rate, weight, mood, appetite
• PDMP review: Looking for doctor shopping, unexpected controlled substances, or concerning patterns
• Compliance check: Are they taking meds as prescribed? Any signs of misuse?

Document everything as you would in-person. Insurance audits and DEA compliance reviews happen — thorough notes protect you.

The Prior Authorization Problem

This is the unsexy part of narcolepsy care: most narcolepsy medications require prior authorization. Modafinil, solriamfetol, pitolisant, and sodium oxybate almost always need insurer approval, which means submitting:

• Confirmation of narcolepsy diagnosis (sleep study results, specialist notes)
• Documentation that patient tried and failed first-line treatments
• Chart notes showing medical necessity

This paperwork takes 30-60 minutes per patient and is usually unpaid. Some insurers require peer-to-peer calls where you justify the prescription to their medical director. It’s tedious, but it’s part of treating narcolepsy.

How telehealth platforms can help: Many platforms (including Klarity) have prior auth support teams who handle the paperwork for you, significantly reducing administrative burden. This alone makes joining a platform more attractive than solo practice.

The Adderall Shortage (and How to Adapt)

Since mid-2022, a national amphetamine shortage has disrupted narcolepsy care. Patients call pharmacies only to find no Adderall in stock, sometimes for weeks. The shortage continues into 2024-2025 with no clear resolution, as DEA manufacturing quotas haven’t kept pace with demand.

Your role as a provider: Be prepared to switch medications quickly. If a patient can’t fill their Adderall prescription, you might switch them to methylphenidate (if available), increase modafinil dosage, or try a non-controlled alternative. Telehealth makes this easier — you can e-prescribe a new medication immediately and follow up within days to assess efficacy. Patients appreciate providers who are proactive rather than telling them ‘just keep calling pharmacies.’

This is a perfect example of why narcolepsy patients value knowledgeable, responsive providers. When medication access is precarious, having a psychiatrist or PMHNP who understands the landscape and can pivot quickly is invaluable.

Reimbursement: What You’ll Actually Get Paid

Let’s talk economics. Narcolepsy medication management is financially viable for telehealth providers if you structure it correctly.

Insurance Reimbursement

E/M codes: Most follow-up visits are coded as 99213 (established patient, 15 min, low-moderate complexity) or 99214 (20-30 min, moderate-high complexity).

• 99213: Medicare allowable ~$90-100, commercial insurance ~$100-130 depending on region
• 99214: Medicare allowable ~$130-150, commercial insurance ~$150-180

Initial evaluations: 99204 or 99205 (45-60 min), reimbursed ~$200-300.

Telehealth parity: In states like CA, NY, IL, and PA, insurers must reimburse telehealth visits at the same rate as in-person (mandated by state law). This makes telehealth narcolepsy care as profitable per visit as an in-office practice, but with lower overhead (no rent, reduced staff needs).

Medicare: Currently covers tele-mental health at full reimbursement. However, NPs are paid 85% of the physician fee schedule under Medicare — so a 99213 that pays a psychiatrist $95 will pay an NP $81. This is a known disparity. Private insurers vary; many pay NPs at 100% in-network, but some follow Medicare’s lead.

Parity violations: Historically, mental health providers have been underpaid by private insurers. A 2024 Illinois report found mental health providers are reimbursed 22% less than other medical specialties on average, driving many psychiatrists out of network. Narcolepsy care might actually help here — since it’s coded as a neurological condition (ICD-10 G47.4x), some insurers process it under medical benefits rather than behavioral health, potentially avoiding mental health carve-out restrictions.

Cash Pay Alternative

Many psychiatrists treating narcolepsy opt out of insurance entirely, charging $150-250 per initial evaluation and $75-150 per follow-up. Given the administrative hassle of prior auths and low mental health reimbursement rates, some providers find cash-pay more profitable and less stressful.

Narcolepsy patients, especially those who’ve struggled to find knowledgeable care, are often willing to pay out-of-pocket for a provider who ‘gets it.’ You’re not just refilling a prescription — you’re managing a rare, complex condition most doctors won’t touch.

Revenue Potential

Let’s do the math on a stable narcolepsy panel:

• 20 narcolepsy patients, each seen quarterly (4 visits/year)
• 80 total visits annually at an average of $120 reimbursement per visit = $9,600/year
• Add 5 new evaluations per year at $200 each = $1,000
• Total: ~$10,600 annually from narcolepsy patients alone

That’s meaningful supplemental income if you’re adding narcolepsy management to an existing psych practice, or it could be part of a larger telehealth panel mix (ADHD, depression, anxiety, etc.).

If you see patients monthly during titration (first 3-6 months), revenue accelerates. Twenty new narcolepsy patients seen monthly for 6 months = 120 visits at $120 = $14,400 in half a year.

The key advantage: recurring, predictable visits. Unlike therapy where patients might graduate or drop out, narcolepsy patients need ongoing medication management indefinitely. That stability is valuable.

Why Platforms Beat Solo Practice for Narcolepsy Care

Here’s the reality: building a narcolepsy telehealth practice from scratch is expensive and time-consuming.

DIY marketing costs: If you try to attract narcolepsy patients on your own, you’re looking at:

• SEO investment: 6-12 months of consistent content creation, website optimization, and backlink building before you see meaningful traffic. Most solo providers don’t have the expertise or budget ($2,000-5,000/month for a competent agency).
• Google Ads: Mental health keywords cost $15-40+ per click. Conversion rates are low (most clicks don’t book). Realistic cost per booked patient: $200-400+ once you factor in wasted ad spend, failed campaigns, and no-shows from cold leads.
• Directory listings: Psychology Today charges $30/month and you’re competing with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+) plus monthly subscription fees.

Add it up: you’re spending $3,000-5,000/month on marketing with uncertain results, and it takes months before you see patients. For most psychiatrists and NPs, that’s an untenable investment.

Platform model: Klarity Health uses a pay-per-appointment model. You pay a standard fee when a qualified patient books with you — no upfront marketing spend, no monthly subscriptions, no ad spend risk. You only pay when you see patients.

The economics are simple: instead of gambling $5,000/month on marketing that might not work, you pay a predictable amount per patient and get guaranteed ROI. Every appointment generates revenue minus the platform fee — no wasted clicks, no failed SEO campaigns.

What you get:

• Pre-qualified patients already matched to your specialty, availability, and licensure
• Built-in telehealth infrastructure (video platform, EHR, e-prescribing, PDMP integrations)
• Insurance and cash-pay patient flow (we handle credentialing and billing)
• Scheduling control — you set your availability and only see patients when you want
• Prior auth support — administrative staff handle much of the paperwork
• Compliance guardrails — platform ensures you’re practicing within state scope and DEA rules

This is especially valuable for NPs in restricted-practice states. If you’re a PMHNP in Texas or Florida, Klarity can facilitate collaborative agreements with supervising psychiatrists so you can treat narcolepsy patients legally. If you’re an independent NP in New York or Illinois, you can practice autonomously within the platform’s infrastructure.

For psychiatrists, the value is efficiency. You don’t want to spend hours on marketing, credentialing, and admin work — you want to see patients and practice medicine. A platform that delivers qualified narcolepsy patients to your virtual door, handles the back-office logistics, and ensures compliance lets you focus on clinical care.

Frequently Asked Questions

Can psychiatrists diagnose narcolepsy via telehealth, or do patients need a sleep study first?

Narcolepsy diagnosis requires a polysomnogram (overnight sleep study) and multiple sleep latency test (MSLT) performed in a sleep lab. Most psychiatrists don’t diagnose narcolepsy from scratch — patients typically come with existing sleep study results or a diagnosis from a sleep specialist. If a patient presents with narcolepsy symptoms but no formal diagnosis, you should refer them for testing before starting stimulant therapy. Once diagnosed, you can manage medications entirely via telehealth.

What’s the difference between narcolepsy type 1 and type 2, and does it matter for prescribing?

Type 1 (with cataplexy) often responds well to sodium oxybate (Xyrem) in addition to stimulants. Type 2 (without cataplexy) is typically managed with wakefulness-promoting medications alone. From a prescribing standpoint, both types use similar first-line meds (modafinil, amphetamines), but type 1 patients may need additional cataplexy-specific treatment. This affects your medication choices but doesn’t change your legal authority to prescribe.

Are there DEA quantity limits on how much stimulant I can prescribe for narcolepsy?

No federal quantity limits exist specifically for narcolepsy. DEA regulations require Schedule II prescriptions to be for a 30-day supply maximum (though some states allow 90-day supplies with post-dated ‘do not fill until’ prescriptions — check your state). Narcolepsy doses are often higher than ADHD doses (patients might take 60-80 mg/day of amphetamine vs. 20-40 mg for ADHD), which is medically appropriate. Document your clinical rationale, and you’re fine.

Can I treat narcolepsy patients across state lines?

You must be licensed in the state where the patient is physically located during the telehealth visit. There’s no interstate compact for psychiatrists or PMHNPs that allows cross-state practice (unlike some professions). If you want to treat patients in multiple states, you need licenses in each state. Many telehealth platforms help streamline multi-state licensing through services like Physician’s Interstate Licensure Compact (for MDs in participating states, but this doesn’t include prescribing authority for NPs).

What do I do if a patient’s pharmacy can’t fill their stimulant prescription due to shortages?

Be proactive. Keep a list of alternative stimulants and non-controlled wakefulness agents. If a patient calls saying their pharmacy is out of Adderall, immediately e-prescribe an alternative (methylphenidate, modafinil, or solriamfetol) and follow up in a week to assess effectiveness. You can also suggest the patient call multiple pharmacies to find one with stock. Some providers maintain relationships with compounding pharmacies, though this is less common for Schedule II drugs.

How do I handle prior authorizations for expensive narcolepsy meds like Wakix or Sunosi?

Expect to submit documentation: sleep study results showing narcolepsy diagnosis, chart notes detailing symptom severity, evidence that first-line meds were tried (if required by the insurer’s step therapy protocol). Most prior auths take 3-7 business days. If your platform has a prior auth team, let them handle it. If you’re solo, build this time into your workflow (or consider charging patients an admin fee for complex auths, disclosed upfront).

What’s my liability risk prescribing stimulants via telehealth?

Your risk is no higher than in-person practice as long as you follow the standard of care: confirm diagnosis, document thoroughly, check PDMP, monitor for side effects and misuse, and prescribe within accepted dosing guidelines. Malpractice insurers generally cover telehealth as long as you’re practicing within your license scope and state/federal laws. If you’re on a platform, they often provide additional liability coverage or indemnification for compliance issues.

Final Takeaway: This Is a Real, Underserved Patient Population

Narcolepsy patients are desperate for providers who understand their condition and can prescribe the medications they need to function. Most have been dismissed, misdiagnosed, or told to ‘just sleep more.’ When they find a psychiatrist or PMHNP who takes their symptoms seriously, manages their meds competently, and is accessible via telehealth, they stay with that provider long-term.

This isn’t a quick-buck specialty. It requires learning the nuances of narcolepsy treatment, navigating complex controlled substance regulations, and dealing with prior authorization headaches. But for providers who value continuity, clinical challenge, and serving a genuinely underserved population, narcolepsy care is deeply rewarding.

If you’re licensed in a state where you can practice your full scope (whether that’s unrestricted MD authority or independent NP practice in NY/IL/CA), narcolepsy telehealth is a viable, profitable addition to your practice. If you’re in a restricted state (TX/FL/PA), you need the right collaborative structure — but it’s still doable.

The regulatory landscape is complex, but it’s not a barrier if you understand the rules. The patient need is enormous. The reimbursement is solid. And the clinical work — helping someone who’s been sleeping 12+ hours a day regain their ability to stay awake, work, and live normally — is genuinely meaningful.

Ready to treat narcolepsy patients via telehealth without the marketing headaches?

Klarity Health connects psychiatrists and PMHNPs with pre-qualified narcolepsy patients who are already matched to your license, specialty, and availability. No upfront marketing costs, no patient acquisition gamble — just a straightforward pay-per-appointment model that guarantees ROI.

We handle:

• Patient intake and scheduling
• Insurance credentialing and billing (or cash-pay processing)
• Telehealth platform and EHR with integrated e-prescribing
• PDMP access and compliance support
• Prior authorization assistance
• Collaborative agreement facilitation for NPs in restricted states

You focus on clinical care. We handle everything else.

[Explore joining Klarity’s provider network →]

Sources and References

1. Axios – ‘COVID-era telehealth prescribing extended again’ (Nov 18, 2024). Reports DEA/HHS extension of controlled substance telehealth flexibilities through Dec 2025. www.axios.com

2. Texas Medical Board – FAQ on Schedule II delegation. Official .gov guidance confirming Texas NP/PA Schedule II prescribing restrictions (hospital/hospice only). www.tmb.state.tx.us

3. California Board of Registered Nursing – AB 890 implementation page. Official state board guidance on 103/104 NP categories and timeline for independent practice (updated 2024). www.rn.ca.gov

4. Florida Statutes – Section 464.012 (Nurse Practice Act, 2021). Primary law text showing 7-day Schedule II limit and psychiatric nurse exception. www.flsenate.gov

5. Rivkin Radler Law Blog – ‘New Law Allows Experienced NPs to Practice Independently in NY’ (Apr 13, 2022). Summary of NY 2023 Budget law eliminating collaborative agreement requirement after 3600 hours. [www.rivkinrounds.com](https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,person%20doctor%27s%20visit%20for%20the
• https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances#:~:text=controlled%20substances%20via%20telemedicine%2C%20with,more%20on
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,drugs%2C%20such%20as
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,require%20a%20physician%20name%3B
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=Please%20note%2C%20the%20law%20requires,certify%20104%20NPs%20until%202026
• https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation#:~:text=1.%20in%20a%20hospital%20facility,has%20elected%20to%20receive%20hospice
• https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All#:~:text=match%20at%20L1566%20limit%20the,455
• https://www.pacodeandbulletin.gov/Display/pacode?file=%2Fsecure%2Fpacode%2Fdata%2F049%2Fchapter21%2Fs21.284.html#:~:text=,may%20not%20delegate%20prescriptive%20authority